ARTICLE | Clinical News
Singulair montelukast regulatory update
January 19, 2009 8:00 AM UTC
FDA said a preliminary analysis of data from clinical trials of Merck's Singulair montelukast and other leukotriene modifying drugs for asthma do not suggest the agents are associated with suicide or ...